A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of SAGE-718 Oral Solution in Patients With Huntington's Disease - Part B
Clinical trial NCT03787758 · COMPLETED
Trial details
- NCT number
- NCT03787758
- Sponsor
- Supernus Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-28
- Primary completion
- 2019-10-07
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.